ImmunoPrecise Antibodies Pre-Tax Profit Margin 2022-2024 | IPA

ImmunoPrecise Antibodies pre-tax profit margin from 2022 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
ImmunoPrecise Antibodies Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-01-31 $0.02B $-0.01B -66.67%
2023-10-31 $0.02B $-0.01B -70.59%
2023-07-31 $0.02B $-0.02B -100.00%
2023-04-30 $0.02B $-0.02B -131.25%
2023-01-31 $0.02B $-0.02B -125.00%
2022-10-31 $0.02B $-0.02B -125.00%
2022-07-31 $0.02B $-0.02B -112.50%
2022-04-30 $0.02B $-0.01B -75.00%
2022-01-31 $0.02B $-0.01B -31.25%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.034B $0.016B
ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $36.275B 19.92
Inspire Medical Systems (INSP) United States $7.566B 0.00
Axonics (AXNX) United States $3.432B 0.00
10x Genomics (TXG) United States $3.275B 0.00
IRhythm Technologies (IRTC) United States $3.196B 0.00
Azenta (AZTA) United States $2.979B 242.82
Olink Holding AB (publ) (OLK) Sweden $2.861B 0.00
Enovis (ENOV) United States $2.812B 20.84
Hims & Hers Health (HIMS) United States $2.412B 0.00
Privia Health (PRVA) United States $2.224B 98.63
Schrodinger (SDGR) United States $1.712B 0.00
Omnicell (OMCL) United States $1.384B 47.83
Phreesia (PHR) United States $1.259B 0.00
Definitive Healthcare (DH) United States $0.828B 0.00
Standard BioTools (LAB) United States $0.728B 0.00
Fulgent Genetics (FLGT) United States $0.643B 0.00
Talkspace (TALK) United States $0.538B 0.00
Health Catalyst (HCAT) United States $0.383B 0.00
Pulmonx (LUNG) United States $0.378B 0.00
Clover Health Investments (CLOV) United States $0.344B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.326B 0.00
P3 Health Partners (PIII) United States $0.202B 0.00
Butterfly Network (BFLY) United States $0.196B 0.00
American Well (AMWL) United States $0.165B 0.00
Outset Medical (OM) United States $0.162B 0.00
Augmedix (AUGX) United States $0.133B 0.00
MSP Recovery (LIFW) United States $0.125B 0.00
TruBridge (TBRG) United States $0.125B 5.33
Mobile-health Network Solutions (MNDR) Singapore $0.108B 0.00
111 (YI) China $0.096B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.068B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Zepp Health (ZEPP) China $0.053B 0.00
Movano (MOVE) United States $0.046B 0.00
EUDA Health Holdings (EUDA) Singapore $0.044B 0.00
Akili (AKLI) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.024B 0.00
Cue Health (HLTH) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.015B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Syra Health (SYRA) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00